arrow
G

Gino Villetti

Chiesi Farmaceutici
H指数:29
被引数:2,848

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Transcriptomic analysis reveals lipid metabolism and macrophage involvement associated with nintedanib treatment in a rat bleomycin model

转录组分析揭示了尼达尼布治疗在博来霉素大鼠模型中与脂质代谢和巨噬细胞参与的相关性

2026-03-220
OAAI
Design, Synthesis, and Biological Evaluation of the Novel Neutrophil Elastase Inhibitor CHF-6333 for the Inhaled Treatment of Bronchiectasis

新型中性粒细胞弹性蛋白酶抑制剂CHF-6333的设计、合成及生物活性评价:用于支气管扩张的吸入治疗

2025-11-010
PRE
Single, double, and triple-hit strategies to establish a long-term premature rabbit model of bronchopulmonary dysplasia

单次、双次和三次打击策略建立长期早产兔支气管肺发育不良模型

2025-01-240
OA
Novel Cyclohexyl Amido Acid Antagonists of Lysophosphatidic Acid Type 1 Receptor for the Treatment of Pulmonary Fibrosis
2025-01-230
PRE
Discovery of CHF-6523, an Inhaled Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease

用于治疗慢性阻塞性肺疾病的吸入选择性PI3Kδ 抑制剂CHF-6523的发现

2024-12-050
PRE
A p75 neurotrophin receptor-sparing nerve growth factor protects retinal ganglion cells from neurodegeneration by targeting microglia
2024-09-090
OA
Discovery, Multiparametric Optimization, and Solid-State Driven Identification of CHF-6550, a Novel Soft Dual Pharmacology Muscarinic Antagonist and β2 Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases
2024-06-100
PRE